Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Avenir Wellness Solutions, Inc. (AVRW : OTC)
 
 • Company Description   
Avenir Wellness Solutions Inc. is a broad platform technology company which develops proprietary wellness, nutraceutical and topical delivery systems. The technology, which is based on current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed. Avenir Wellness Solutions Inc., formerly known as CURE Pharmaceutical Holding Corp., is based in SHERMAN OAKS, CA.

Number of Employees: 11

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.01 Daily Weekly Monthly
20 Day Moving Average: 16,276 shares
Shares Outstanding: 90.20 (millions)
Market Capitalization: $0.82 (millions)
Beta: 0.10
52 Week High: $0.06
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -36.36% -39.24%
12 Week -18.75% -31.43%
Year To Date -69.67% -71.50%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5805 Sepulveda Blvd. Suite 420
-
Sherman Oaks,CA 91403
USA
ph: 424-273-8675
fax: 805-487-7163
investor@avenirwellness.com http://www.avenirwellness.com
 
 • General Corporate Information   
Officers
Nancy Duitch - Chief Executive Officer and Director
Joel Bennett - Chief Financial Officer
Gene Salkind - Director
Robert Costantino - Director
Gerald Bagg - Director

Peer Information
Avenir Wellness Solutions, Inc. (CHCR)
Avenir Wellness Solutions, Inc. (ESRX)
Avenir Wellness Solutions, Inc. (MYDP)
Avenir Wellness Solutions, Inc. (COR)
Avenir Wellness Solutions, Inc. (GBCS)
Avenir Wellness Solutions, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 23127P104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/24
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 90.20
Most Recent Split Date: (:1)
Beta: 0.10
Market Capitalization: $0.82 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.40
EPS Growth
vs. Year Ago Period: 66.67%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -81.08%
vs. Previous Quarter: -33.10%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©